Search research articles
Contact Us
Filters
Showing results (61-70 of 277) with videos related to
Page
of 28
Sort By:
British Journal of Haematology
|
November 10, 2009
A comprehensive evaluation of the prognostic significance of 13q deletions in patients with B-chronic lymphocytic leukaemia
Daniel L Van Dyke, Tait D Shanafelt, Timothy G Call, et al.
Journal of the National Cancer Institute. Monographs
|
September 1, 2014
Medical history, lifestyle, family history, and occupational risk factors for lymphoplasmacytic lymphoma/Waldenström's macroglobulinemia: the InterLymph Non-Hodgkin Lymphoma Subtypes Project
Claire M Vajdic, Ola Landgren, Mary L McMaster, et al.
Leukemia & Lymphoma
|
July 18, 2012
The Functional Assessment of Cancer Therapy - General (FACT-G) is valid for monitoring quality of life in patients with non-Hodgkin lymphoma
Kathleen J Yost, Carrie A Thompson, David T Eton, et al.
American Journal of Hematology
|
June 8, 2012
Elevated pretreatment serum levels of interferon-inducible protein-10 (CXCL10) predict disease relapse and prognosis in diffuse large B-cell lymphoma patients
Stephen M Ansell, Matthew J Maurer, Steven C Ziesmer, et al.
Annals of Epidemiology
|
November 14, 2012
The association between early life and adult body mass index and physical activity with risk of non-Hodgkin lymphoma: impact of gender
Jennifer L Kelly, Zachary S Fredericksen, Mark Liebow, et al.
Blood
|
November 19, 2008
B-cell count and survival: differentiating chronic lymphocytic leukemia from monoclonal B-cell lymphocytosis based on clinical outcome
Tait D Shanafelt, Neil E Kay, Greg Jenkins, et al.
American Journal of Hematology
|
May 22, 2023
Impact of type 2 diabetes on mortality, cause of death, and treatment in chronic lymphocytic leukemia
Emelie Curovic Rotbain, Cristine Allmer, Klaus Rostgaard, et al.
The American Journal of Psychiatry
|
March 3, 2010
Association of mu-opioid receptor variants and response to citalopram treatment in major depressive disorder
Holly A Garriock, Michael Tanowitz, Jeffrey B Kraft, et al.
Cancer
|
June 26, 2010
Age at diagnosis and the utility of prognostic testing in patients with chronic lymphocytic leukemia
Tait D Shanafelt, Kari G Rabe, Neil E Kay, et al.
Journal of Oncology Practice
|
March 26, 2015
Impact of ibrutinib and idelalisib on the pharmaceutical cost of treating chronic lymphocytic leukemia at the individual and societal levels
Tait D Shanafelt, Bijan J Borah, Heidi D Finnes, et al.
Page
of 28
Search research articles
Search
Showing results (61-70 of 277) with videos related to
Sort By:
Page
of 28
British Journal of Haematology
|
November 10, 2009
A comprehensive evaluation of the prognostic significance of 13q deletions in patients with B-chronic lymphocytic leukaemia
Daniel L Van Dyke, Tait D Shanafelt, Timothy G Call, et al.
Journal of the National Cancer Institute. Monographs
|
September 1, 2014
Medical history, lifestyle, family history, and occupational risk factors for lymphoplasmacytic lymphoma/Waldenström's macroglobulinemia: the InterLymph Non-Hodgkin Lymphoma Subtypes Project
Claire M Vajdic, Ola Landgren, Mary L McMaster, et al.
Leukemia & Lymphoma
|
July 18, 2012
The Functional Assessment of Cancer Therapy - General (FACT-G) is valid for monitoring quality of life in patients with non-Hodgkin lymphoma
Kathleen J Yost, Carrie A Thompson, David T Eton, et al.
American Journal of Hematology
|
June 8, 2012
Elevated pretreatment serum levels of interferon-inducible protein-10 (CXCL10) predict disease relapse and prognosis in diffuse large B-cell lymphoma patients
Stephen M Ansell, Matthew J Maurer, Steven C Ziesmer, et al.
Annals of Epidemiology
|
November 14, 2012
The association between early life and adult body mass index and physical activity with risk of non-Hodgkin lymphoma: impact of gender
Jennifer L Kelly, Zachary S Fredericksen, Mark Liebow, et al.
Blood
|
November 19, 2008
B-cell count and survival: differentiating chronic lymphocytic leukemia from monoclonal B-cell lymphocytosis based on clinical outcome
Tait D Shanafelt, Neil E Kay, Greg Jenkins, et al.
American Journal of Hematology
|
May 22, 2023
Impact of type 2 diabetes on mortality, cause of death, and treatment in chronic lymphocytic leukemia
Emelie Curovic Rotbain, Cristine Allmer, Klaus Rostgaard, et al.
The American Journal of Psychiatry
|
March 3, 2010
Association of mu-opioid receptor variants and response to citalopram treatment in major depressive disorder
Holly A Garriock, Michael Tanowitz, Jeffrey B Kraft, et al.
Cancer
|
June 26, 2010
Age at diagnosis and the utility of prognostic testing in patients with chronic lymphocytic leukemia
Tait D Shanafelt, Kari G Rabe, Neil E Kay, et al.
Journal of Oncology Practice
|
March 26, 2015
Impact of ibrutinib and idelalisib on the pharmaceutical cost of treating chronic lymphocytic leukemia at the individual and societal levels
Tait D Shanafelt, Bijan J Borah, Heidi D Finnes, et al.
Page
of 28